TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Tharimmune ( (THAR) ) has shared an update.
On September 5, 2025, Tharimmune, Inc. received confirmation from Nasdaq that it complies with Listing Rule 5550(b)(1) after reporting stockholders’ equity of $6,876,335 as of August 31, 2025. This compliance closes the matter with Nasdaq, potentially stabilizing the company’s market position and reassuring stakeholders.
The most recent analyst rating on (THAR) stock is a Buy with a $17.00 price target. To see the full list of analyst forecasts on Tharimmune stock, see the THAR Stock Forecast page.
More about Tharimmune
Average Trading Volume: 10,023,049
Technical Sentiment Signal: Buy
Current Market Cap: $23.53M
For detailed information about THAR stock, go to TipRanks’ Stock Analysis page.